Skip to main content

Table 3 Type and dose of outpatient initiation of β-blockers, stratified by LVEF

From: Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization

β-Blocker Initiated

LVSD (n = 362)

No LVSD (n = 283)

N

Dose, mg/24 hr Median (IQR)

N

Dose, mg/24 hr Median (IQR)

Atenolol

12

25 (12.5-25)

56

25 (25–25)

Carvedilol

63

12.5 (6.25-25)

12

9.375 (6.25-18.75)

Metoprolol Succinate

124

25 (12.5-37.5)

42

12.5 (12.5-25)

Metoprolol Tartrate

163

50 (25–50)

173

50 (25–50)

Hospitalization in next 30 days following β-blocker initiation (unadjusted)

 

6 (0.93%)

 

9 (1.40%)

  1. LVSD = left ventricular systolic dysfunction (LVEF ≤40% or moderate/severe LV systolic dysfunction). The 6 patients initiated on a β-blocker other than those listed were excluded.